-
Intuitive Surgical Inc. (ISRG $512.06)
- $512.06 Fwd P/E: 77.02X Cap: $188.54B
- View ISRG Profile
- View Questions on ISRG
Detailed Quote
Questions on this company?
Become a Member
Company Profile
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Intuitive Surgical Inc. (ISRG $512.06)
- $512.06 Fwd P/E: 77.02X Cap: $188.54B
- View ISRG Profile
- View Questions on ISRG
-
Eli Lilly and Company (LLY $793.01)
- $793.01 Fwd P/E: 64.33X Cap: $751.56B
- View LLY Profile
- View Questions on LLY
-
UnitedHealth Group Incorporated (DE) (UNH $304.10)
- $304.10 Fwd P/E: 12.54X Cap: $271.69B
- View UNH Profile
- View Questions on UNH
Q: Hello, I've been holding UHN in my RRSP for a while, but the stock has taken a significant hit with a 33% loss. Given its current stagnation, I'm thinking of selling it and reallocating the funds. I have a few options in mind: I could buy a call option with a strike price of $79 expiring on Dec 27, which might give me a chance to recover some losses if the stock rebounds. Alternatively, I could sell UHN and use the proceeds to increase my stake in other healthcare stocks, such as LLY or ISRG, which I believe have more potential. Or, I could cut my losses entirely and exit the healthcare insurance sector. Which direction makes the most sense? Thanks
-
Alphabet Inc. (GOOG $181.31)
- $181.31 Fwd P/E: 19.94X Cap: $2.16T
- View GOOG Profile
- View Questions on GOOG
-
Intuitive Surgical Inc. (ISRG $512.06)
- $512.06 Fwd P/E: 77.02X Cap: $188.54B
- View ISRG Profile
- View Questions on ISRG
-
Booking Holdings Inc. (BKNG $5,717.10)
- $5,717.10 Fwd P/E: 35.65X Cap: $186.03B
- View BKNG Profile
- View Questions on BKNG
-
Stryker Corporation (SYK $389.46)
- $389.46 Fwd P/E: 53.35X Cap: $150.86B
- View SYK Profile
- View Questions on SYK
-
Constellation Software Inc. (CSU $4,888.06)
- $4,888.06 Fwd P/E: 103.71X Cap: $105.01B
- View CSU Profile
- View Questions on CSU
- View Reports on CSU
-
kneat.com inc. (KSI $6.03)
- $6.03 Cap: $566M
- View KSI Profile
- View Questions on KSI
- View Reports on KSI
-
Axon Enterprise Inc. (AXON $729.62)
- $729.62 Fwd P/E: 177.05X Cap: $57.06B
- View AXON Profile
- View Questions on AXON
-
Celestica Inc. (CLS $161.03)
- $161.03 Fwd P/E: 45.36X Cap: $18.26B
- View CLS Profile
- View Questions on CLS
-
Propel Holdings Inc. (PRL $36.29)
- $36.29 Fwd P/E: 19.52X Cap: $1.48B
- View PRL Profile
- View Questions on PRL
- View Reports on PRL
-
Brookfield Corporation Class A Limited (BN $63.16)
- $63.16 Fwd P/E: 228.25X Cap: $104.05B
- View BN Profile
- View Questions on BN
-
Lumine Group Inc. (LMN $51.88)
- $51.88 Cap: $12.92B
- View LMN Profile
- View Questions on LMN
- View Reports on LMN
-
Nebius Group N.V. (NBIS $44.30)
- $44.30 Cap: $11.05B
- View NBIS Profile
- View Questions on NBIS
Q: CSU has grown too large a position in my portfolio, and I am very reluctantly (sadly even) forcing myself to sell a portion.
Along with some additional free capital, I am considering adding four new positions.
I am indifferent to industry, size or region. This is all about growth.
I am willing to hold for many years, but I want companies that are proven winners and very well-positioned to grow aggressively in the long term. Ideally, companies that are standouts in their industry.
How would you rank the above positions in terms of risk (1-10), short-term growth (1-10) and long-term growth (1-10)?
If you have additional suggestions not on my list that may be more suitable, please include them in your analysis.
Thanks for your outstanding service. I owe the bulk of my financial success to you and your team.
Subtract as many credits as needed.
Along with some additional free capital, I am considering adding four new positions.
I am indifferent to industry, size or region. This is all about growth.
I am willing to hold for many years, but I want companies that are proven winners and very well-positioned to grow aggressively in the long term. Ideally, companies that are standouts in their industry.
How would you rank the above positions in terms of risk (1-10), short-term growth (1-10) and long-term growth (1-10)?
If you have additional suggestions not on my list that may be more suitable, please include them in your analysis.
Thanks for your outstanding service. I owe the bulk of my financial success to you and your team.
Subtract as many credits as needed.
-
Gilead Sciences Inc. (GILD $109.64)
- $109.64 Fwd P/E: 24.06X Cap: $136.38B
- View GILD Profile
- View Questions on GILD
-
Intuitive Surgical Inc. (ISRG $512.06)
- $512.06 Fwd P/E: 77.02X Cap: $188.54B
- View ISRG Profile
- View Questions on ISRG
-
AbbVie Inc. (ABBV $192.45)
- $192.45 Fwd P/E: 83.33X Cap: $344.44B
- View ABBV Profile
- View Questions on ABBV
-
Johnson & Johnson (JNJ $156.90)
- $156.90 Fwd P/E: 17.54X Cap: $377.51B
- View JNJ Profile
- View Questions on JNJ
-
Eli Lilly and Company (LLY $793.01)
- $793.01 Fwd P/E: 64.33X Cap: $751.56B
- View LLY Profile
- View Questions on LLY
-
Medtronic plc. (MDT $89.92)
- $89.92 Fwd P/E: 24.76X Cap: $115.21B
- View MDT Profile
- View Questions on MDT
-
Stryker Corporation (SYK $389.46)
- $389.46 Fwd P/E: 53.35X Cap: $150.86B
- View SYK Profile
- View Questions on SYK
-
Thermo Fisher Scientific Inc (TMO $434.86)
- $434.86 Fwd P/E: 25.26X Cap: $164.15B
- View TMO Profile
- View Questions on TMO
-
Health Care Select Sector SPDR (XLV $135.19)
- $135.19 Fwd P/E: 65.56X Cap: $34.68B
- View XLV Profile
- View Questions on XLV
-
iShares U.S. Medical Devices ETF (IHI $60.97)
- $60.97 Fwd P/E: 105.73X Cap: $4.48B
- View IHI Profile
- View Questions on IHI
-
Sabra Health Care REIT Inc. (SBRA $18.46)
- $18.46 Fwd P/E: 30.93X Cap: $4.39B
- View SBRA Profile
- View Questions on SBRA
-
Healthcare Realty Trust Incorporated (HR $16.10)
- $16.10 Cap: $5.65B
- View HR Profile
- View Questions on HR
-
iShares U.S. Pharmaceuticals ETF (IHE $67.18)
- $67.18 Fwd P/E: 57.72X Cap: $567M
- View IHE Profile
- View Questions on IHE
-
Catalyst Pharmaceuticals Inc. (CPRX $21.81)
- $21.81 Fwd P/E: 13.92X Cap: $2.66B
- View CPRX Profile
- View Questions on CPRX
Q: There was an article in the Globe and Mail today by David Rosenberg about the aging population and he suggested health care related investments such as health care REITS, pharma, devices, and services. What do you think of this idea and can you give me a few recommendations in canada and the US for each of the 4 categories (health reits, pharma, devices, sefrvices)? A mix of ETFS and individual stocks would be great.
Insiders
Share Information
SEC Filings
News and Media